2024-05-06 18:23:58
The company AstraZeneca will stop marketing its vaccine against covid-19, Vaxzevria, starting tomorrow, Tuesday, in the European Union at its own request, according to the British-Swedish company in a statement.
Astrazeneca covid vaccine. EFE/EPA/PA
The European Commission (EC) notified on March 27 that, at the request of the owner – AstraZeneca –, it is withdrawing the marketing authorization of this vaccine, one of those investigated, manufactured and marketed against covid, starting tomorrow, Tuesday, the 7th. of May.
AstraZeneca justifies the withdrawal of its medicine due to the lack of demand and the surplus of vaccines currently available on the market against covid.
“As multiple updated vaccines have been developed for Covid-19 variants, there is now a surplus of vaccines available. This has caused a decrease in demand for Vaxzervria, which is no longer manufactured or supplied,” the pharmaceutical company notes in the note.
End of marketing of the AstraZeneca covid vaccine in Europe
A spokesperson for the European Commission confirmed this afternoon to EFE that, at the company’s request, the European authorization to market AstraZeneca’s covid-19 vaccine will be withdrawn tomorrow and pointed out that this fact is not uncommon when the products are not in demand in the European Union.
The laboratory, which made the withdrawal request on March 5 before Brussels, congratulates itself on the role played by Vaxzevria in ending the pandemic.
Along these lines, he points out that, “according to independent estimates, in the first year of use alone, more than 6.5 million lives were saved and more than 3 billion doses were supplied worldwide.”
The third vaccine against coronavirus to arrive in Spain
Vaxzevria, the vaccine of AstraZeneca against covid-19, it was the third to arrive in Spain, on February 6, 2021, once authorized by the European Commission on January 29 of that year after the review to which all vaccines undergo by of the European Medicines Agency.
It was the third vaccine to receive approval from European regulators against covid, after those made by Pfizer/BioTech and Moderna.
View of the AstraZeneca headquarters. EFE/Dan Himbrechts/Archive
#AstraZeneca #covid #vaccine #stops #marketed #Europe